Antonio
May 15, 2008
ARIAD to Present Clinical Data at ASCO on the Anti-Tumor and Safety...
“This large Phase 1 dose-ranging trial in diverse cancer patients provides further support for the use of oral deforolimus”
Edward M. Fitzgerald, 617-621-2345 or Sheryl Seapy, 949-608-0841 ARIAD Pharmaceuticals, Inc. via PR-inside.com
Comments
Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.
| Topic | Updated | Last By | Comments |
|---|---|---|---|
| Great Derangement' author to speak at bookstore... | Jun 27 | Bob | 4 |
| Critics of Redwood landfil plan hit snag | Jun '08 | Bruce Baum | 5 |
| Big bucks to house sex offender | Jun '08 | Just a Lockw... | 10 |
| Moving virus research off island could be costl... | Jun '08 | Beevo | 1 |
| Poor Mexican village is rich in faith | May '08 | ignacio cerv... | 1 |
| Real estate cold; real estate TV hot | May '08 | KCc | 1 |
| Woman arrested after baby found | May '08 | mz YAAY | 13 |
Most Popular
